5. Culturally Competent Care for Substance Users Diagnosed with HIV Disease
Choosing an Approach to Substance Use Treatment
Clinicians who are managing HIV-positive substance users should consider addressing the patient’s substance use treatment at each clinic visit, as both drug and alcohol abuse are associated with increased risk for inadequate antiretroviral adherence. [Chander 2006, Hicks 2007] This should be done in a compassionate way that is based on a trusting, culturally sensitive patient-provider relationship that is not likely to discourage or alienate the patient from remaining in treatment for both substance use and HIV disease. However, the practitioner also should be prepared to discuss any suspected relapse or continued use. [Wartenberg 1991]
Treatment options
Pharmacologic interventions. Several proven treatment options are available for users of certain substances. For opiate dependence, methadone, buprenorphine, and combination buprenorphine/naloxone are available. [Vocci 2005] For patients addicted to alcohol, there are disulfiram, acamprosate, and naltrexone. However, proven pharmacologic treatments for cocaine and methamphetamine use are not yet available.
Counseling. Use of any of these drugs alone does not cure substance abuse problems. Rather, their role is to help stabilize the patient’s condition so that one or more of various psychosocial approaches can be used either to modify the patient's thinking, behavior, and environment or to prepare her or him to return to an environment that may not be ideal. [Francis 2003] These can include regular participation over a period of time in either individual or group counseling of various types, such as cognitive behavioral therapy or one of the 12-step programs like Alcoholics Anonymous or Narcotics Anonymous. Depending on a particular patient’s needs and the clinician’s judgment, some HIV-positive substance users may benefit from inpatient treatment programs. [Fiellin 2004] The practitioner should assess which of these treatment options is most appropriate for the particular patient and is consistent with his or her particular cultural beliefs and practices; the patient’s readiness to undertake treatment is also a critical consideration.
Selecting an HIV Treatment Approach
Assessing the likelihood of adherence. When the practitioner and the patient together have agreed that the patient is ready to initiate antiretroviral therapy, the practitioner should perform an assessment of whether any medical or social factors in the patient’s life could contribute to a risk of non-adherence or inadequate adherence, which has been associated with, among other things, younger age, female gender, recent incarceration, depression, and a provider’s limited experience in managing HIV patients. [Celentano 1998, Strathdee 1998].
Poor adherence has also been associated with active substance use. [Bouhnik 2003] On the other hand, patients who are now former substance users or who are receiving treatment for substance use have been found to have adherence rates comparable to those in patients who have never been substance users. [Hicks 2007] Practitioners who are concerned that a patient may not be adherent should offer adherence counseling and/or DOT.
Selecting an antiretroviral regimen. If the patient has previously received antiretroviral therapy, the practitioner should review with the patient the dates when treatment was received and any adverse events. For antiretroviral-experienced patients, genotype and phenotype analyses should be performed to determine any preexisting antiretroviral resistance. Previous or current substance users may also be more likely to experience more antiretroviral adverse events. [Carrieri 2007]
Patients should be queried regarding approximately how many daily pills they may find acceptable and their concerns about potential adverse events. Once-daily antiretroviral regimens are preferable in most cases, although issues of potential resistance or restrictions due to adverse events may limit the available choices of regimens. The current version of the DHHS Guidelines for the Use of Antiretroviral Agents in HIV-1-infected Adults and Adolescents provides a complete discussion of selecting appropriate antiretroviral regimens for patients who are receiving opioid replacement therapy or treatment for comorbid conditions. [DHHS Guidelines, 2013]